Børge Sørvoll
Direttore Finanziario/CFO presso ARCTICZYMES TECHNOLOGIES ASA
Patrimonio netto: 232 629 $ in data 31/05/2024
Posizioni attive di Børge Sørvoll
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ARCTICZYMES TECHNOLOGIES ASA | Direttore Finanziario/CFO | 01/10/2014 | - |
| Contatto Relazioni con gli Investitori | 01/10/2014 | - | |
Biotec BetaGlucans AS
 Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Part of Lallemand, Inc., Biotec BetaGlucans AS is a Norwegian company that specializes in developing M-Gard®, an immunomodulator that enhances the body's defense mechanisms against pathogens. The company is based in Tromsø, Norway. The technology behind M-Gard® has been successfully developed for alternative indications and applications, including nutraceuticals, wound care, and immunotherapy. The CEO of the company is Jethro Holter. Biotec BetaGlucans was acquired by Danstar Ferment AG from ArcticZymes Technologies ASA on December 31, 2020 for $7.93 million. | Presidente | - | - |
Storia della carriera di Børge Sørvoll
Precedenti posizioni note di Børge Sørvoll
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Front Exploration AS
 Front Exploration AS Contract DrillingIndustrial Services Front Exploration AS explores oil and gas and is ultimately controlled by the Government of Denmark. The company is based in Tromsø, Norway. Front Exploration was acquired by Ørsted A/S on June 27, 2012. | Direttore Finanziario/CFO | - | - |
Subsea 7 Norway AS
 Subsea 7 Norway AS Miscellaneous Commercial ServicesCommercial Services Part of Subsea 7 SA, Subsea 7 Norway AS is a Norwegian company that engages in general trading activities. The company is based in Stavanger, Norway. The CEOs are John Evans, Monica Th. Bjørkmann. The company was founded in 1985. | Corporate Officer/Principal | - | - |
| Troms Kraft Invest AS | Amministratore Delegato | - | - |
| Direttore Finanziario/CFO | - | - |
Formazione di Børge Sørvoll
| University of Wyoming | Masters Business Admin |
Statistiche
Distribuzione geografica
| Norvegia | 6 |
| Stati Uniti | 2 |
Posizioni
| Director of Finance/CFO | 3 |
| Investor Relations Contact | 1 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
| Industrial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ARCTICZYMES TECHNOLOGIES ASA | Health Technology |
| Aziende private | 4 |
|---|---|
Front Exploration AS
Front Exploration AS Contract DrillingIndustrial Services Front Exploration AS explores oil and gas and is ultimately controlled by the Government of Denmark. The company is based in Tromsø, Norway. Front Exploration was acquired by Ørsted A/S on June 27, 2012. | Industrial Services |
Subsea 7 Norway AS
Subsea 7 Norway AS Miscellaneous Commercial ServicesCommercial Services Part of Subsea 7 SA, Subsea 7 Norway AS is a Norwegian company that engages in general trading activities. The company is based in Stavanger, Norway. The CEOs are John Evans, Monica Th. Bjørkmann. The company was founded in 1985. | Commercial Services |
| Troms Kraft Invest AS | |
Biotec BetaGlucans AS
Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Part of Lallemand, Inc., Biotec BetaGlucans AS is a Norwegian company that specializes in developing M-Gard®, an immunomodulator that enhances the body's defense mechanisms against pathogens. The company is based in Tromsø, Norway. The technology behind M-Gard® has been successfully developed for alternative indications and applications, including nutraceuticals, wound care, and immunotherapy. The CEO of the company is Jethro Holter. Biotec BetaGlucans was acquired by Danstar Ferment AG from ArcticZymes Technologies ASA on December 31, 2020 for $7.93 million. | Health Technology |
- Borsa valori
- Insiders
- Børge Sørvoll
- Esperienza
